2018
DOI: 10.4103/jehp.jehp_66_18
|View full text |Cite
|
Sign up to set email alerts
|

Periodontal therapy as an adjunctive modality for HbA1c reduction in type-2 diabetic patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…One of the key factors in treating DM is glycemic control. Previous studies showed that individuals with higher glycated hemoglobin (also known as hemoglobin A1C (HbA1c)) had an increased risk of periodontal disease [ 73 , 74 , 75 ]. The mechanism associated with the two diseases is probably a multifactorial one.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…One of the key factors in treating DM is glycemic control. Previous studies showed that individuals with higher glycated hemoglobin (also known as hemoglobin A1C (HbA1c)) had an increased risk of periodontal disease [ 73 , 74 , 75 ]. The mechanism associated with the two diseases is probably a multifactorial one.…”
Section: Resultsmentioning
confidence: 99%
“…As depicted in this review, in insulin resistance, there is an increase in pro-inflammatory cytokines such as interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-α [ 40 , 52 ] and ROS [ 53 ]. Furthermore, in T2DM there is an increase in TNF-α, IL-1β, IL-6, and IL-18 [ 71 ], which are known to elevate HbA1C, which increases the risk for periodontal disease [ 73 , 74 , 75 ]. Moreover, the inflammatory state is known to activate MMP, which, together with ROS, will result in periodontal breakdown [ 76 ].…”
Section: Discussionmentioning
confidence: 99%
“…With respect to the review findings reported, there were limitations of heterogeneity in the included study data, mainly about the outcomes assessed and reported, and varying the follow-up periods. Similarly, neither the cases reported, nor the reviewed studies, took into consideration auxiliary modalities such as laser and photodynamic therapy [ 35 ], the effect of systemic illnesses on implant osseointegration and bone healing [ 37 , 38 ], and special scenarios such as immediate implant placement and bone graft sites [ 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…While the present clinical reports were focused mainly on evaluating the clinical outcomes of topical oxygen therapy, its effect on bone level gain could be included in the scope of future clinical trials. Similarly, the role of systemic illnesses and confounding factors such as smoking and parafunctional habits on the development and progression of gingivitis and periodontitis [ 50 ], and how they may be influenced by local oxygen-based therapy, would require further investigation.…”
Section: Discussionmentioning
confidence: 99%